What is the Role of Respiratory Viruses in Community-Acquired Pneumonia?. What is the Best Therapy for Influenza and Other Viral Causes of Community-Acquired Pneumonia?

Infectious Disease Clinics of North America

Volumn 27, Issue 1, 2013, Pages 157-175

  Pavia, Andrew T ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Antiviral agents; Influenza; Respiratory viral infections; Respiratory viruses; Viral pneumonia

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; CIDOFOVIR; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; IMMUNOGLOBULIN; OSELTAMIVIR; PALIVIZUMAB; RIBAVIRIN; RIMANTADINE; ZANAMIVIR;

ADENOVIRUS; ADULT DISEASE; BACTERIAL PNEUMONIA; BOCAVIRUS; CHILDHOOD DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CORONAVIRUS; CYTOMEGALOVIRUS; DIFFERENTIAL DIAGNOSIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN METAPNEUMOVIRUS; INFLUENZA; INFLUENZA VIRUS; LENGTH OF STAY; MEASLES VIRUS; MIXED INFECTION; MORTALITY; NON SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; OUTCOME ASSESSMENT; PARAINFLUENZA VIRUS; PARECHOVIRUS; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY VIRUS; REVIEW; RHINOVIRUS; RISK REDUCTION; VARICELLA ZOSTER VIRUS; VIRAL RESPIRATORY TRACT INFECTION; VIRUS DETECTION; VIRUS INFECTION; VIRUS PNEUMONIA;

ANTIVIRAL AGENTS; BACTERIAL VACCINES; COINFECTION; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; INFLUENZA, HUMAN; NEURAMINIDASE; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL;

EID: 84873537776     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2012.11.007     Document Type: Review

References (136)

1. Ison M.G., Michaels M.G. RNA respiratory viral infections in solid organ transplant recipients. Am J Transplant 2009, 9(Suppl 4):S166-S172.
2. Kim Y.J., Boeckh M., Englund J.A. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med 2007, 28:222-242.
3. Jartti T., Jartti L., Peltola V., et al. Identification of respiratory viruses in asymptomatic subjects: asymptomatic respiratory viral infections. Pediatr Infect Dis J 2008, 27:1103-1107.
4. Falsey A.R., Cunningham C.K., Barker W.H., et al. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 1995, 172:389-394.
5. Dowell S.F., Anderson L.J., Gary H.E., et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis 1996, 174:456-462.
6. Jennings L.C., Anderson T.P., Beynon K.A., et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 2008, 63:42-48.
7. Johansson N., Kalin M., Tiveljung-Lindell A., et al. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 2010, 50:202-209.
8. Johnstone J., Majumdar S.R., Fox J.D., et al. Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest 2008, 134:1141-1148.
9. Lieberman D., Shimoni A., Shemer-Avni Y., et al. Respiratory viruses in adults with community-acquired pneumonia. Chest 2010, 138:811-816.
10. Falsey A.R., Hennessey P.A., Formica M.A., et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005, 352:1749-1759.
11. Zhou H., Thompson W.W., Viboud C.G., et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis 2012, 54:1427-1436.
12. Thompson W.W., Shay D.K., Weintraub E., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
13. Walsh E.E., Peterson D.R., Falsey A.R. Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly and high-risk adults possible?. J Infect Dis 2007, 195:1046-1051.
14. Louria D., Blumenfeld H., Ellis J., et al. Studies on influenza in the pandemic of 1957-58. II. Pulmonary complications of Influenza. J Clin Invest 1959, 38:213-265.
15. Iverson A.R., Boyd K.L., McAuley J.L., et al. Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis 2011, 203:880-888.
16. McCullers J.A. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006, 19:571-582.
17. Morens D.M., Taubenberger J.K., Fauci A.S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008, 198:962-970.
18. Ampofo K., Gesteland P.H., Bender J., et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics 2006, 118:2409-2417.
19. Jain S., Benoit S.R., Skarbinski J., et al. Influenza-associated pneumonia among hospitalized patients with 2009 pandemic influenza A (H1N1) virus-United States, 2009. Clin Infect Dis 2012, 54:1221-1229.
20. Lee N., Chan P.K., Lui G.C., et al. Complications and outcomes of pandemic 2009 influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza?. J Infect Dis 2011, 203:1739-1747.
21. Murata Y., Walsh E.E., Falsey A.R. Pulmonary complications of interpandemic influenza A in hospitalized adults. J Infect Dis 2007, 195:1029-1037.
22. Louie J.K., Acosta M., Winter K., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302:1896-1902.
23. Schildgen V., van den Hoogen B., Fouchier R., et al. Human metapneumovirus: lessons learned over the first decade. Clin Microbiol Rev 2011, 24:734-754.
24. Falsey A.R., Erdman D., Anderson L.J., et al. Human metapneumovirus infections in young and elderly adults. J Infect Dis 2003, 187:785-790.
25. Williams J.V., Harris P.A., Tollefson S.J., et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004, 350:443-450.
26. Foulongne V., Guyon G., Rodiere M., et al. Human metapneumovirus infection in young children hospitalized with respiratory tract disease. Pediatr Infect Dis J 2006, 25:354-359.
27. Caracciolo S., Minini C., Colombrita D., et al. Human metapneumovirus infection in young children hospitalized with acute respiratory tract disease: virologic and clinical features. Pediatr Infect Dis J 2008, 27:406-412.
28. Falsey A.R. Human metapneumovirus infection in adults. Pediatr Infect Dis J 2008, 27:S80-S83.
29. Walsh E.E., Peterson D.R., Falsey A.R. Human metapneumovirus infections in adults: another piece of the puzzle. Arch Intern Med 2008, 168:2489-2496.
30. Widmer K., Zhu Y., Williams J.V., et al. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis 2012, 206:56-62.
31. Hamelin M.E., Cote S., Laforge J., et al. Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease. Cin Infect Dis 2005, 41:498-502.
32. Hilleman M.R., Werner J.H. Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med 1954, 85:183-188.
33. Ison M.G. Adenovirus infections in transplant recipients. Clin Infect Dis 2006, 43:331-339.
34. Gerber S.I., Erdman D.D., Pur S.L., et al. Outbreak of adenovirus genome type 7d2 infection in a pediatric chronic-care facility and tertiary-care hospital. Clin Infect Dis 2001, 32:694-700.
35. Sanchez M.P., Erdman D.D., Torok T.J., et al. Outbreak of adenovirus 35 pneumonia among adult residents and staff of a chronic care psychiatric facility. J Infect Dis 1997, 176:760-763.
36. Gray G.C., Goswami P.R., Malasig M.D., et al. Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. For the Adenovirus Surveillance Group. Clin Infect Dis 2000, 31:663-670.
37. Dudding B.A., Top F.H., Winter P.E., et al. Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971. Am J Epidemiol 1973, 97:187-198.
38. van der Veen J., Oei K.G., Abarbanel M.F. Patterns of infections with adenovirus types 4, 7 and 21 in military recruits during a 9-year survey. J Hyg (Lond) 1969, 67:255-268.
39. Hakim F.A., Tleyjeh I.M. Severe adenovirus pneumonia in immunocompetent adults: a case report and review of the literature. Eur J Clin Microbiol Infect Dis 2008, 27:153-158.
40. Potter R.N., Cantrell J.A., Mallak C.T., et al. Adenovirus-associated deaths in US military during postvaccination period, 1999-2010. Emerg Infect Dis 2012, 18:507-509.
41. Lewis P.F., Schmidt M.A., Lu X., et al. A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J Infect Dis 2009, 199:1427-1434.
42. Metzgar D., Osuna M., Kajon A.E., et al. Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. J Infect Dis 2007, 196:1465-1473.
43. Henrickson K.J. Parainfluenza viruses. Clin Microbiol Rev 2003, 16:242-264.
44. Iwane M.K., Edwards K.M., Szilagyi P.G., et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004, 113:1758-1764.
45. Weinberg G.A., Hall C.B., Iwane M.K., et al. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr 2009, 154:694-699.
46. Marx A., Gary H.E., Marston B.J., et al. Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection. Clin Infect Dis 1999, 29:134-140.
47. Charles P.G., Whitby M., Fuller A.J., et al. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis 2008, 46:1513-1521.
48. Templeton K.E., Scheltinga S.A., van den Eeden W.C., et al. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 2005, 41:345-351.
49. Pene F., Merlat A., Vabret A., et al. Coronavirus 229E-related pneumonia in immunocompromised patients. Clin Infect Dis 2003, 37:929-932.
50. van der Hoek L., Pyrc K., Jebbink M.F., et al. Identification of a new human coronavirus. Nat Med 2004, 10:368-373.
51. Woo P.C., Lau S.K., Chu C.M., et al. Characterization and complete genome sequence of a novel coronavirus HKU1 from patients with pneumonia. J Virol 2005, 79:884-895.
52. Gaunt E.R., Hardie A., Claas E.C., et al. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol 2010, 48:2940-2947.
53. Kuypers J., Martin E.T., Heugel J., et al. Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics 2007, 119:e70-e76.
54. van der Hoek L., Ihorst G., Sure K., et al. Burden of disease due to human coronavirus NL63 infections and periodicity of infection. J Clin Virol 2010, 48:104-108.
55. Dare R.K., Fry A.M., Chittaganpitch M., et al. Human coronavirus infections in rural Thailand: a comprehensive study using real-time reverse-transcription polymerase chain reaction assays. J Infect Dis 2007, 196:1321-1328.
56. Garbino J., Crespo S., Aubert J.D., et al. A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (non-SARS)-related human coronavirus infection. Clin Infect Dis 2006, 43:1009-1015.
57. Mackay I.M. Human rhinoviruses: the cold wars resume. J Clin Virol 2008, 42:297-320.
58. Arden K.E., Mackay I.M. Newly identified human rhinoviruses: molecular methods heat up the cold viruses. Rev Med Virol 2010, 20:156-176.
59. Papadopoulos N.G., Sanderson G., Hunter J., et al. Rhinoviruses replicate effectively at lower airway temperatures. J Med Virol 1999, 58:100-104.
60. Papadopoulos N.G., Bates P.J., Bardin P.G., et al. Rhinoviruses infect the lower airways. J Infect Dis 2000, 181:1875-1884.
61. Kennedy J.L., Turner R.B., Braciale T., et al. Pathogenesis of rhinovirus infection. Curr Opin Virol 2012, 2:287-293.
62. Falsey A.R., Walsh E.E., Hayden F.G. Rhinovirus and coronavirus infection-associated hospitalizations among older adults. J Infect Dis 2002, 185:1338-1341.
63. Cheuk D.K., Tang I.W., Chan K.H., et al. Rhinovirus infection in hospitalized children in Hong Kong: a prospective study. Pediatr Infect Dis J 2007, 26:995-1000.
64. Miller E.K., Lu X., Erdman D.D., et al. Rhinovirus-associated hospitalizations in young children. J Infect Dis 2007, 195:773-781.
65. Louie J.K., Roy-Burman A., Guardia-Labar L., et al. Rhinovirus associated with severe lower respiratory tract infections in children. Pediatr Infect Dis J 2009, 28:337-339.
66. Cevey-Macherel M., Galetto-Lacour A., Gervaix A., et al. Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr 2009, 168:1429-1436.
67. Jain S, Ampofo K, Arnold SR, et al. Etiology of community-acquired pneumonia among hospitalized children in the United States: preliminary data from the CDC Etiology of Pneumonia in the Community (EPIC) study. Presented at the Infectious Diseases Society of America 49th Annual Meeting. Boston, October 20-23, 2011. Abstract 168.
68. Juven T., Mertsola J., Waris M., et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000, 19:293-298.
69. Michelow I.C., Olsen K., Lozano J., et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004, 113:701-707.
70. Tsolia M.N., Psarras S., Bossios A., et al. Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis 2004, 39:681-686.
71. Allander T. Human bocavirus. J Clin Virol 2008, 41:29-33.
72. Brieu N., Guyon G., Rodiere M., et al. Human bocavirus infection in children with respiratory tract disease. Pediatr Infect Dis J 2008, 27:969-973.
73. Fry A.M., Lu X., Chittaganpitch M., et al. Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J Infect Dis 2007, 195:1038-1045.
74. Christensen A., Nordbo S.A., Krokstad S., et al. Human bocavirus in children: mono-detection, high viral load and viraemia are associated with respiratory tract infection. J Clin Virol 2010, 49:158-162.
75. Harvala H., Wolthers K.C., Simmonds P. Parechoviruses in children: understanding a new infection. Curr Opin Infect Dis 2010, 23:224-230.
76. Abed Y., Boivin G. Human parechovirus types 1, 2 and 3 infections in Canada. Emerg Infect Dis 2006, 12:969-975.
77. McCracken G.H. Diagnosis and management of pneumonia in children. Pediatr Infect Dis J 2000, 19:924-928.
78. Garcia-Garcia M.L., Calvo C., Pozo F., et al. Spectrum of respiratory viruses in children with community-acquired pneumonia. Pediatr Infect Dis J 2012, 31:808-813.
79. Pilishvili T., Lexau C., Farley M.M., et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010, 201:32-41.
80. Ampofo K., Pavia A.T., Stockmann C.R., et al. Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era. Pediatr Infect Dis J 2011, 30:1100-1103.
81. Falsey A.R., Walsh E.E. Viral pneumonia in older adults. Clin Infect Dis 2006, 42:518-524.
82. Rice T.W., Rubinson L., Uyeki T.M., et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med 2012, 40:1487-1498.
83. Ampofo K., Bender J., Sheng X., et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 2008, 122:229-237.
84. Talbot T.R., Poehling K.A., Hartert T.V., et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med 2005, 118:285-291.
85. Johansson N., Kalin M., Hedlund J. Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia. Scand J Infect Dis 2011, 43:609-615.
86. Ruuskanen O., Lahti E., Jennings L.C., et al. Viral pneumonia. Lancet 2011, 377:1264-1275.
87. Virkki R., Juven T., Rikalainen H., et al. Differentiation of bacterial and viral pneumonia in children. Thorax 2002, 57:438-441.
88. File T.M. New diagnostic tests for pneumonia: what is their role in clinical practice?. Clin Chest Med 2011, 32:417-430.
89. Nascimento-Carvalho C.M., Cardoso M.R., Barral A., et al. Procalcitonin is useful in identifying bacteraemia among children with pneumonia. Scand J Infect Dis 2010, 42:644-649.
90. Toikka P., Irjala K., Juven T., et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000, 19:598-602.
91. Gilbert D.N. Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J Clin Microbiol 2010, 48:2325-2329.
92. Gilbert D.N. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis 2011, 52(Suppl 4):S346-S350.
93. Schuetz P., Briel M., Christ-Crain M., et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis 2012, 55:651-662.
94. Franquet T. Imaging of pulmonary viral pneumonia. Radiology 2011, 260:18-39.
95. Guo W., Wang J., Sheng M., et al. Radiological findings in 210 paediatric patients with viral pneumonia: a retrospective case study. Br J Radiol 2012, 85(1018):1385-1389.
96. Fiore A.E., Fry A., Shay D., et al. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011, 60:1-24.
97. Hayden F.G., Pavia A.T. Antiviral management of seasonal and pandemic influenza. J Infect Dis 2006, 194(Suppl 2):S119-S126.
98. Kaiser L., Wat C., Mills T. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003, 163:1667.
99. Lee N., Chan P.K., Hui D.S., et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009, 200:492-500.
100. McGeer A., Green K.A., Plevneshi A., et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007, 45:1568-1575.
101. Lee N., Choi K.W., Chan P.K., et al. Outcomes of adults hospitalised with severe influenza. Thorax 2010, 65:510-515.
102. Jain S., Kamimoto L., Bramley A.M., et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361:1935-1944.
103. Bautista E., Chotpitayasunondh T., Gao Z., et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010, 362:1708-1719.
104. Siston A.M., Rasmussen S.A., Honein M.A., et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010, 303:1517-1525.
105. Yu H., Feng Z., Uyeki T.M., et al. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis 2011, 52:457-465.
106. Yang S.G., Cao B., Liang L.R., et al. Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus. PLoS One 2012, 7:e29652.
107. Louie J.K., Yang S., Acosta M., et al. Treatment With neuraminidase inhibitors for critically ill patients with Influenza A (H1N1) pdm09. Clin Infect Dis 2012, 55(9):1198-1204.
108. Eriksson C.O., Graham D.A., Uyeki T.M., et al. Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A. Pediatr Crit Care Med 2012, 13(6):625-631.
109. Kumar A., Zarychanski R., Pinto R., et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009, 302:1872-1879.
110. Hsu J., Santesso N., Mustafa R., et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med 2012, 156(7):512-524.
111. Randolph A.G., Vaughn F., Sullivan R., et al. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics 2011, 128:e1450-e1458.
112. Harper S.A., Bradley J.S., Englund J.A., et al. Seasonal influenza in adults and children. Diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1003-1032.
113. Ginocchio C.C., Zhang F., Manji R., et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009, 45:191-195.
114. Uyeki T.M., Prasad R., Vukotich C., et al. Low sensitivity of rapid diagnostic test for influenza. Clin Infect Dis 2009, 48:e89-e92.
115. Dharan N.J., Gubareva L.V., Meyer J.J., et al. Infections with oseltamivir-resistant influenza A (H1N1) virus in the United States. JAMA 2009, 301:1034-1041.
116. Moscona A. Global transmission of oseltamivir-resistant influenza. N Engl J Med 2009, 360:953-956.
117. Fry A.M., Gubareva L.V. Understanding influenza virus resistance to antiviral agents: early warning signs for wider community circulation. J Infect Dis 2012, 206:145-147.
118. Hayden F.G., de Jong M.D. Emerging influenza antiviral resistance threats. J Infect Dis 2011, 203:6-10.
119. Hurt A.C., Hardie K., Wilson N.J., et al. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A (H1N1) pdm09 influenza in Australia. J Infect Dis 2012, 206:148-157.
120. Krilov L.R. Respiratory syncytial virus disease: update on treatment and prevention. Expert Rev Anti Infect Ther 2011, 9:27-32.
121. Boeckh M., Englund J., Li Y., et al. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis 2007, 44:245-249.
122. Ventre K., Randolph A.G. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev 2007, (1). CD000181.
123. Shachor-Meyouhas Y., Ben-Barak A., Kassis I. Treatment with oral ribavirin and IVIG of severe human metapneumovirus pneumonia (HMPV) in immune compromised child. Pediatr Blood Cancer 2011, 57:350-351.
124. Refaat M., McNamara D., Teuteberg J., et al. Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia. J Heart Lung Transplant 2008, 27:699-700.
125. Doan M.L., Mallory G.B., Kaplan S.L., et al. Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J Heart Lung Transplant 2007, 26:883-889.
126. Darr S., Madisch I., Heim A. Antiviral activity of cidofovir and ribavirin against the new human adenovirus subtype 14a that is associated with severe pneumonia. Clin Infect Dis 2008, 47:731-732.
127. Toth K., Spencer J.F., Dhar D., et al. Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model. Proc Natl Acad Sci U S A 2008, 105:7293-7297.
128. Hayden F.G., Herrington D.T., Coats T.L., et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clin Infect Dis 2003, 36:1523-1532.
129. DeVincenzo J.P., El Saleeby C.M., Bush A.J. Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis 2005, 191:1861-1868.
130. Fodha I., Vabret A., Ghedira L., et al. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity. J Med Virol 2007, 79:1951-1958.
131. Gerna G., Piralla A., Rovida F., et al. Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients. J Med Virol 2009, 81:1498-1507.
132. Martin E.T., Kuypers J., Heugel J., et al. Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus. Diagn Microbiol Infect Dis 2008, 62:382-388.
133. Bradley J.S., Byington C.L., Shah S.S., et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011, 53:e25-e76.
134. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl 2):S27-S72.
135. Abed Y., Boivin G. Treatment of respiratory virus infections. Antiviral Res 2006, 70:1-16.
136. Nichols W.G., Peck Campbell A.J., Boeckh M. Respiratory viruses other than influenza virus: impact and therapeutic advances. Clin Microbiol Rev 2008, 21:274-290.